|Bid||0.4550 x 78655600|
|Ask||0.4600 x 42535300|
|Day's range||0.4500 - 0.4700|
|52-week range||0.2750 - 0.5900|
|Beta (5Y monthly)||0.77|
|PE ratio (TTM)||N/A|
|Earnings date||24 Feb 2021|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||03 Mar 2011|
|1y target est||1.14|
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Mayne Pharma Group...
Mayne Pharma Group Limited (ASX: MYX) is pleased to announce the commercial launch of a generic version of ORTHO-CEPT® (desogestrel and ethinyl estradiol 0.15 mg / 0.03 mg) tablets to customers in the US.
If you want to know who really controls Mayne Pharma Group Limited ( ASX:MYX ), then you'll have to look at the makeup...